trending Market Intelligence /marketintelligence/en/news-insights/trending/D22aqYdYo1kLSMjZlRoJpQ2 content esgSubNav
In This List

Madrigal Pharmaceuticals plans $100M common stock offering

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Madrigal Pharmaceuticals plans $100M common stock offering

Madrigal Pharmaceuticals Inc. is planning an underwritten public offering of $100 million worth of its common stock.

The company plans to grant the underwriters a 30-day option to buy up to an additional 15% of the shares offered.

Goldman Sachs & Co. LLC is the sole book runner of the offering.